- Home
- CLDX vs LAZ Comparison
CLDX vs LAZ Comparison
Compare CLDX & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | LAZ |
|---|---|---|
| Founded | N/A | 1848 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 1995 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CLDX | LAZ |
|---|---|---|
| Price | $28.86 | $40.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 10 |
| Target Price | ★ $64.00 | $43.38 |
| AVG Volume (30 Days) | 899.2K | ★ 1.6M |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.20 |
| Revenue | $12,743,000.00 | ★ $3,186,466,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | $75.84 | $19.40 |
| P/E Ratio | ★ N/A | $34.21 |
| Revenue Growth | ★ 87.78 | 1.48 |
| 52 Week Low | $22.33 | $34.13 |
| 52 Week High | $45.14 | $58.75 |
Technical Indicators
Market Signals| Indicator | CLDX | LAZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 56.54 |
| Support Level | $28.26 | $39.46 |
| Resistance Level | $31.83 | $45.71 |
| Average True Range (ATR) | 1.44 | 1.57 |
| MACD | 0.15 | 0.30 |
| Stochastic Oscillator | 26.35 | 53.71 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About LAZ Lazard Inc.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.